| 000 | 01456 a2200217 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20251204100958.0 | ||
| 008 | 251204b |||||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_aGozdas, Hasan Tahsin _927663 |
||
| 245 | _aReversible bilateral ototoxicity in a patient with chronic hepatitis B during peginterferon alpha-2a treatment | ||
| 250 | _aVol.47(1), Jan-Feb | ||
| 260 |
_aMumbai _bWolter Kluwer _c2015 |
||
| 300 | _a121-122p. | ||
| 520 | _aPeginterferon alpha-2a (PEG IFN α-2a) is frequently used in chronic hepatitis B (CHB)treatment. Numerous adverse events can be noted during this therapy such as flu-like disease, rash, weight loss and depression. However, PEG IFN α-2a related ototoxicity seems to be an uncommon entity. Ototoxicity can be detected objectively by audiometry. In this paper, we present a case of CHB who developed reversible bilateral ototoxicity during PEG IFN α-2a treatment. Due to ototoxicity detected objectively by audiogram, treatment was ceased at sixth month and ototoxicity completely recovered one month after stopping the drug. | ||
| 650 | 0 |
_aPHARMACOLOGY _94774 |
|
| 700 |
_aKarabay, Oguz _921519 |
||
| 773 | 0 |
_tIndian Journal of Pharmacology _x0253-7613 _dAndheri - Mumbai Wolters Kluwer India Private Limited |
|
| 856 |
_uhttps://journals.lww.com/iphr/fulltext/2015/47010/reversible_bilateral_ototoxicity_in_a_patient_with.24.aspx _yClick here |
||
| 942 |
_2ddc _cAR |
||
| 999 |
_c23709 _d23709 |
||